SALT LAKE CITY (ABC4) – Utah is a center of scientific development. Think Research Park, Silicon Slopes, and universities across the state. But according to UNESCO (the United Nations Education, Science and Culture Organization), less than 30% of researchers are women, and many of them are published less, paid less, and do not have the same opportunities for advancement as their male counterparts. Monday night’s IN FOCUS discussion highlighted three women who are at the cutting edge of science and technology in Utah.
Women shown in films throughout March
Dr. Lisa Abegglen is Assistant Professor of Hematology at the University of Utah and the Scientific Director of Peel Therapeutics. Dr. Andrea Mazzocchi is the co-founder and CEO of Known Medicine. Both joined Rosie Nguyen of ABC4 on CW30 News at 7 p.m. to share their experiences in science, their businesses, and where they think we stand in the fight against cancer, their personal experiences as women working in Science and business work how it compares to their male counterparts and what they advise young women pursuing a career in this field.
Nobel science first: more than a winner, not a man
Chandana Haque, Executive Director of Altitude Lab, spoke about why diversity in science and technology matters to their personal experiences as women in science, how women tend to experience more barriers in science of what it means to lead a biology incubator through her business and where her laboratory is about to bring something new to market.
Miss Murray 2020 shares 2 science projects to get kids excited about STEM
To see the full IN FOCUS discussion with Dr. Abegglen, Dr. To watch Mazzocchi and Haque, click the video at the top of the article.
Catch IN FOCUS discussions with Rosie Nguyen of ABC4 on weekdays on the 7pm CW30 news
Rosie Nguyen is an award-winning journalist who joined the ABC4 News team as a reporter in January 2018. In September 2020, at 7 p.m., she started a new trip as a presenter for CW30 News. She continues her passion for social justice and community issues through the nightly “In Focus” discussions.
Comments are closed.